Shotgun metagenomes enriched for viromes from stool samples of healthy donors and active ulcerative colitis patients under donor fecal microbiota filtrate and microbiota transfer raw Illumina sequence reads
Download from source ↗Dataset overview
Bacterial and viral assemblages in ulcerative colitis patients following fecal microbiota and fecal filtrate transfer.
Abstract
Fecal microbiota filtrate transfer is discussed as a safe alternative to fecal microbiota transfer (FMT) to treat ulcerative colitis. We investigated modulation of viral and bacterial composition during fecal microbiota filtrate transfer followed by FMT in six patients with active ulcerative colitis (where clinical activity improved in three patients after filtrate transfer) and combined 16S ribosomal RNA gene amplicon sequencing with a virome analysis pipeline including fast viral particle enrichment and metagenome mapping to detect frequencies of 45,033 reference bacteriophage genomes. We showed that after antibiotic treatment and during filtrate transfer, the bacterial community typically adopted a stable composition distinct to that before antibiotic treatment, with no change toward a donor community. FMT in contrast typically changed the bacterial community to a community with similarity to donor(s). There were no indications of an establishment of predominant donor viruses during filtrate transfer but a remodeling of the virome. In contrast, the establishment of donor viruses during FMT correlated with the predicted hosts established during such transfer. Our approach warrants further investigation in a randomized trial to evaluate larger therapeutic interventions in a comparable and efficient manner.
Study facts
- Organism
- —
- Platform
- Illumina NovaSeq
- Age group
- —
- Disease groups
- Non-IBD controls, Ulcerative colitis
- Anatomical sites
- —
Data availability
Specific data assets have not been resolved from the source yet — see the source repository below for the full file listing.
File types
application/x-gzip
Strengths & limitations for reuse
Strengths
- Raw reads are advertised
- Participant-to-sample mapping is available
- Participant counts are documented
Limitations
- Not documented: feature/otu tables are advertised
- Not documented: taxonomic tables are advertised
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.paired_end |
True |
Illumina paired-end data (R1 and R2) Section |
assay.platform |
Illumina NovaSeq |
Illumina NovaSeq sequencing of test stool samples yielded datasets Section |
assay.read_length |
250 |
16.3 10 6 ± 0.7 10 6 250b paired-end reads per sample Section |
assay.sequencing_type |
shotgun_metagenomics |
Shotgun metagenomes enriched for viromes Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.disease_activity_metadata_available |
True |
active ulcerative colitis patients Section |
cohort.non_ibd_controls |
5 |
from 5 healthy stool donors Section |
cohort.study_design |
longitudinal |
patients ... at different times of treatment Section |
cohort.total_participants |
11 computed |
Human stool samples of six Ulcerative Colitis patients ... from 5 healthy stool donors Section |
cohort.treatment_exposure_documented |
True |
patients under donor fecal microbiota filtrate and microbiota transfer Section |
cohort.ulcerative_colitis_participants |
6 |
Human stool samples of six Ulcerative Colitis patients Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.open_access |
True from source |
openAccess Section |
data_assets.raw_reads |
True |
raw fastq Illumina reads of shotgun metagenomes Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.longitudinal_sampling |
True |
patients ... at different times of treatment Section |
specimens.participant_to_sample_mapping_available |
True |
healthy donors (D1-D5) and Ulcerative colitis patients (P1-P6) at different days Section |
specimens.sample_type |
stool |
Human stool samples of six Ulcerative Colitis patients Section |